You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

idelalisib

Showing 26 - 50 of 68
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma Trial in United States (Entospletinib,

Terminated
Has Results
  • Chronic Lymphocytic Leukemia
  • +3 more
  • La Jolla, California
  • +12 more
May 18, 2020

Chronic Lymphocytic Leukemia, Lymphoma, Non-Hodgkin Trial in United States (Idelalisib)

Terminated
Has Results
  • Chronic Lymphocytic Leukemia
  • Lymphoma, Non-Hodgkin
  • Idelalisib
  • Huntsville, Alabama
  • +17 more
Aug 22, 2019

Follicular Lymphoma, Small Lymphocytic Lymphoma Trial in United States (Idelalisib, Rituximab)

Terminated
Has Results
  • Follicular Lymphoma
  • Small Lymphocytic Lymphoma
  • Idelalisib
  • Rituximab
  • Long Beach, California
  • +5 more
May 1, 2019

B Cells in High-risk CLL After Idelalisib-rituximab

Withdrawn
  • Chronic Lymphocytic Leukemia
  • Biospecimen Collection
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Apr 12, 2019

Chronic Lymphocytic Leukemia Trial in United States (ABT-199)

Completed
  • Chronic Lymphocytic Leukemia
  • La Jolla, California
  • +14 more
Dec 29, 2021

Chronic Lymphocytic Leukemia Trial in Worldwide (Idelalisib, Rituximab, Bendamustine)

Completed
Has Results
  • Chronic Lymphocytic Leukemia
  • Idelalisib
  • +3 more
  • Huntsville, Alabama
  • +105 more
Mar 2, 2020

Healthcare Resources in Chronic Lymphocytic Leukemia Initiating

Completed
  • Chronic Lymphocytic Leukemia
    • Calgary, Alberta, Canada
    • +12 more
    Jul 7, 2022

    Chronic Lymphocytic Leukemia Trial in Worldwide (Idelalisib)

    Terminated
    Has Results
    • Chronic Lymphocytic Leukemia
    • Idelalisib
    • Huntsville, Alabama
    • +44 more
    Aug 12, 2019

    Chronic Lymphocytic Leukaemia Treated With Idelalisib and

    Completed
    • Chronic Lymphocytic Leukaemia
    • Dublin, Ireland
    • +15 more
    Apr 11, 2019

    Follicular Lymphoma, Small Lymphocytic Lymphoma, Lymphoplasmacytic Lymphoma Trial in Worldwide (Idelalisib)

    Completed
    Has Results
    • Follicular Lymphoma
    • +3 more
    • Idelalisib
    • Fullerton, California
    • +40 more
    Jun 14, 2019

    Indolent Non-Hodgkin's Lymphoma, Follicular Lymphoma, Small Lymphocytic Lymphoma Trial in Palo Alto, New York (Idelalisib)

    Completed
    Has Results
    • Indolent Non-Hodgkin's Lymphoma
    • +3 more
    • Idelalisib
    • Palo Alto, California
    • +1 more
    Oct 19, 2018

    DLBCL, Mediastinal B-cell Lymphoma Trial in Worldwide (Idelalisib, Rituximab, Ifosfamide)

    Withdrawn
    • Diffuse Large B-Cell Lymphoma
    • Mediastinal B-cell Lymphoma
    • Idelalisib
    • +4 more
    • Lille, France
    • +6 more
    Dec 7, 2018

    Advanced Solid Tumor Trial in Sutton, Manchester (SL-901)

    Recruiting
    • Advanced Solid Tumor
    • Sutton, Surrey, United Kingdom
    • +1 more
    May 16, 2022

    Hodgkin Lymphoma Trial in New York, Houston, Seattle (Idelalisib)

    Completed
    Has Results
    • Hodgkin Lymphoma
    • Idelalisib
    • New York, New York
    • +2 more
    Oct 19, 2018

    Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) Trial in United States (Idelalisib, Rituximab)

    Terminated
    Has Results
    • Chronic Lymphocytic Leukemia (CLL)
    • Small Lymphocytic Lymphoma (SLL)
    • La Jolla, California
    • +5 more
    Oct 19, 2018

    Chronic Lymphocytic Leukemia Trial in Worldwide (Idelalisib, Rituximab, Placebo to match idelalisib)

    Completed
    Has Results
    • Chronic Lymphocytic Leukemia
    • Idelalisib
    • +2 more
    • Huntsville, Alabama
    • +71 more
    May 1, 2019

    Chronic Lymphocytic Leukemia Trial in Worldwide (Idelalisib, Ofatumumab)

    Terminated
    Has Results
    • Chronic Lymphocytic Leukemia
    • Duarte, California
    • +79 more
    Aug 5, 2019

    Relapsed/Refractory Chronic Lymphocytic Leukemia, Chronic Lymphocytic Leukemia, Leukemia Trial in Switzerland (Ibrutinib,

    Active, not recruiting
    • Relapsed/Refractory Chronic Lymphocytic Leukemia
    • +2 more
    • Aarau, Switzerland
    • +10 more
    Mar 10, 2022

    Chronic Lymphocytic Leukemia Trial in Worldwide (Idelalisib, Chlorambucil, Obinutuzumab)

    Terminated
    Has Results
    • Chronic Lymphocytic Leukemia
    • Idelalisib
    • +2 more
    • Santa Barbara, California
    • +17 more
    Oct 19, 2018

    Chronic Lymphocytic Leukemia Trial in Milano (Venetoclax, Imbruvica Oral Product)

    Active, not recruiting
    • Chronic Lymphocytic Leukemia
    • Milano, MI, Italy
      Ospedale San Raffaele
    Apr 2, 2022

    Cancer Target Therapy Efficacy

    Active, not recruiting
    • Cancer
    • RNA sequencing
    • +5 more
    • Walnut, California
    • +6 more
    Sep 13, 2021

    Follicular Lymphoma Trial (YY-20394)

    Not yet recruiting
    • Follicular Lymphoma
    • (no location specified)
    May 6, 2020

    Allergic Rhinitis Trial in Vienna (CAL-101, Placebo)

    Completed
    • Allergic Rhinitis
    • Vienna, Austria
      Vienna Challenge Chamber
    Oct 19, 2018

    Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Portland (drug, device, biological)

    Completed
    • Acute Lymphoblastic Leukemia
    • Acute Myeloid Leukemia
    • Portland, Oregon
      OHSU Knight Cancer Institute
    May 21, 2020

    B-cell Chronic Lymphocytic Leukemia (CLL) With 17p Deletion Trial in Worldwide (Idelalisib, Rituximab)

    Terminated
    Has Results
    • B-cell Chronic Lymphocytic Leukemia (CLL) With 17p Deletion
    • Tucson, Arizona
    • +55 more
    Oct 19, 2018